Enhance Diagnostics today announced its official rebrand to Enhance Health, reflecting the company’s evolution from a single diagnostic solution to a comprehensive health monitoring platform designed to support earlier insights, continuous tracking, and improved clinical decision-making.
Originally founded as Enhance Diagnostics, the company first focused on developing a novel ammonia breath test to support metabolic and organ health clinical assessment. As the technology advanced and clinical applications came into focus, the company’s vision expanded beyond a single test to a platform addressing a broader need for ongoing, real-world health monitoring.
The new name, Enhance Health, represents this broader mission: to deliver a total monitoring platform that integrates innovative sensing technologies, data analytics, and clinically meaningful insights to support patients, providers, and health systems over time, not just at a single point of measurement.
“This rebrand reflects what our platform has become and where we are going,” said Matthew Leming, CEO and co-founder. “Enhance Health is focused on enabling continuous, actionable health insights that can help guide care, monitor disease progression, and support better outcomes across a range of clinical use cases.”
Enhance Health’s platform approach is designed to move beyond episodic diagnostics, enabling longitudinal monitoring that aligns with the growing demand for proactive, personalized, and data-driven healthcare. The company will continue advancing its foundational technologies while expanding capabilities that support broader clinical and population health applications. Enhance Health’s platform approach is designed to convert chronic disease monitoring into personalized, data-driven healthcare.
For more information, visit enhancehealthinc.com
About VIC Tech
Enhance Health is part of the portfolio of VIC Tech, a venture studio focused on creating companies from innovative academic research. Enhance's Breeze is the third device from a VIC Tech portfolio company to receive Breakthrough Device Designation from the FDA, highlighting VIC’s consistent track record of advancing impactful health technologies toward clinical and commercial success.